Associate Director, Technology Evaluation – Radiopharmaceutical Innovation

We are seeking an experienced and forward‑thinking Associate Director, Technology Evaluation to join a growing, science‑driven client focused on transforming cancer diagnosis and patient management through innovative molecular imaging technologies.

About the Role

Reporting to the VP, Innovation & Strategy, this role will lead the identification, scientific assessment, and strategic evaluation of new radiopharmaceutical opportunities, with a focus on oncology. You will help shape the company’s R&D strategy by scouting emerging technologies, building academic collaborations, and assessing the potential of novel diagnostic and therapeutic agents. This is a unique opportunity to combine scientific expertise with strategic influence, driving the next generation of molecular imaging solutions from discovery to development.

Key Responsibilities

• Scout, evaluate, and prioritize new radiopharmaceutical technologies and product opportunities across oncology and related disease areas.
• Conduct scientific, technical, and IP landscaping to inform investment and partnership decisions.
• Collaborate closely with internal R&D teams and global innovation groups to shape early‑stage development strategies.
• Manage due diligence and gap analysis for prioritized external opportunities, coordinating with cross‑functional experts.
• Develop strategic academic and research collaborations, including joint grant‑funded initiatives.
• Maintain a strong understanding of emerging scientific and clinical trends in cancer diagnostics and imaging.
• Support internal portfolio planning by providing insights into competitive and adjacent technologies.
• Present findings clearly and credibly to senior leadership, contributing to high‑quality decision‑making.

Qualifications and Experience

• PhD (or equivalent experience) in life sciences, molecular imaging, pharmacology, or oncology‑related field.
• Strong experience in academic research or R&D within pharma or biotech, ideally with exposure to early‑stage development.
• Deep understanding of oncology biology, diagnostic imaging, and emerging therapeutic modalities.
• Experience in technology scouting, evaluation, or competitive intelligence within a scientific context.
• Track record of managing external collaborations or research partnerships.
• Excellent scientific communication, analytical thinking, and project management skills.
• Familiarity with radiopharmaceuticals or nuclear medicine is advantageous but not essential.

Why Join

• Influence the strategic direction of next‑generation radiopharmaceuticals in a fast‑evolving field.
• Collaborate with world‑class scientists, innovators, and global partners.
• Be part of a mission‑led organization advancing diagnostic imaging and improving outcomes for patients with cancer.
• Competitive compensation package and opportunities for professional growth.

If you’re passionate about applying scientific insight to strategic innovation in oncology diagnostics, we’d love to hear from you. Apply now to join a growing team that’s redefining the future of molecular imaging.

Tshering Sherpa

tsherpa@planet-pharma.co.uk